Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$19.1M
+22.3% from 2023
Prescriptions
1,135
$16,807.48 per claim
Patients
239
276 prescribers
Total spending, 2024
$19.1M
$79,817.94 per patient
Medicare prescription drug plans paid $19.1M for Rozlytrek in 2024, for 1,135 prescriptions and refills to 239 patients (up 22.3% from 2023). The average cost per claim was $16,807.48.
California had the highest Medicare cost for Rozlytrek in 2024: $3.8M for 210 claims, followed by New York ($1.5M).
Rachelle C Olsen, physician assistant in Los Angeles, CA, had the highest Medicare cost for Rozlytrek in 2024: 19 claims costing $386K.
Rozlytrek is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rachelle C Olsen Los Angeles, CA | Physician Assistant | 19 | Under 11 | $386K |
| Mohammed Almubarak Morgantown, WV | Hematology-Oncology | 12 | Under 11 | $354K |
| Anh Pham |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 224 | 776 | 192 | $12.3M |
| 2023 | 228 | 951 | 205 | $15.6M |
| 2024 | 276 | 1,135 | 239 | $19.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 16 |
| Under 11 |
| $276K |
| Sanaz N Ghafouri Woodland, CA | Hematology-Oncology | 15 | Under 11 | $267K |
| Jeremy P Cetnar Portland, OR | Medical Oncology | 14 | Under 11 | $249K |
| Pedro G Solivan Ortiz Rio Piedras, PR | Hematology-Oncology | 12 | Under 11 | $243K |
| Joshua Harris Port Jefferson Station, NY | Hospitalist | 12 | Under 11 | $242K |
| Tarek M Mekhail Orlando, FL | Hematology-Oncology | 12 | Under 11 | $234K |
| James W Evans Alabaster, AL | Medical Oncology | 12 | Under 11 | $234K |
| Samir Alsawah Port Huron, MI | Hematology-Oncology | 12 | Under 11 | $228K |
| Emily A Duffield New Haven, CT | Nurse Practitioner | 11 | Under 11 | $223K |
| 1124087135 | Hematology-Oncology | 11 | Under 11 | $219K |
| Nasser H Hanna Indianapolis, IN | Hematology-Oncology | 11 | Under 11 | $214K |
| Martin J Edelman Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 11 | Under 11 | $207K |
| Amandeep Gill Marysville, CA | Hematology-Oncology | 11 | Under 11 | $203K |
| Vipin Ramprasad Lohiya Fayetteville, GA | Hematology-Oncology | 22 | Under 11 | $197K |
| Sai-Hong I Ou Orange, CA | Internal Medicine | 11 | Under 11 | $195K |
| Xiuning Le Boston, MA | Internal Medicine | 13 | Under 11 | $177K |
| Kimberly N Nojima Chan New York, NY | Nurse Practitioner | 13 | Under 11 | $168K |
| Aswini Padmanabhan Baldwin Park, CA | Internal Medicine | 12 | Under 11 | $167K |
| Kelly M Smith Lafayette, CO | Hematology-Oncology | 11 | Under 11 | $160K |
| Jose Silva Chambersburg, PA | Hematology-Oncology | 11 | Under 11 | $157K |
| Trevor Feinstein Fayetteville, GA | Hematology-Oncology | 11 | Under 11 | $156K |
| Shirish M Gadgeel Detroit, MI | Medical Oncology | 11 | Under 11 | $150K |
| Clifton P Layman El Paso, TX | Internal Medicine | 11 | Under 11 | $149K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 1,135 | $19.1M |